SCHEMBL4148041

SCHEMBL4148041

C/C(NC(=O)c1cccc(F)c1O)=C(\CCC(C)C)C(=O)NCCc1cccc(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OPRK1 P41145 1/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 3/20 0.38
LMNA P02545 2/20 0.38
HTT P42858 1/20 0.38
CNR1 P21554 1/20 0.37
TAAR1 Q96RJ0 2/20 0.36
TP53 P04637 1/20 0.36
PLAAT3 P53816 2/20 0.36
PLAAT5 Q96KN8 2/20 0.36
PLAAT2 Q9NWW9 2/20 0.36
PLAAT4 Q9UL19 2/20 0.36
SNCA P37840 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148046 1.00 ALDH1A1 (0.40) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4142774 0.80 CNR1 (0.44) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4142778 0.80 CNR1 (0.44) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4142769 0.80 CNR1 (0.44) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL14535996 0.77 CNR1 (0.42) OPRM1OPRD1OPRK1RAB9ANPC1
SCHEMBL4152846 0.72 RAB9A (0.45) ALDH1A1MEN1KMT2AOPRM1OPRD1
SCHEMBL4152840 0.72 RAB9A (0.45) ALDH1A1MEN1KMT2AOPRM1OPRD1
SCHEMBL4156820 0.68 TAAR1 (0.47) ALDH1A1MEN1HPGDKMT2ASMN1; SMN2
SCHEMBL4135180 0.68 TAAR1 (0.49) MEN1KMT2AOPRM1OPRD1OPRK1
SCHEMBL4135175 0.68 TAAR1 (0.49) MEN1KMT2AOPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed
US-20090137557-A1 Calcilytic Compounds SMITHKLINE BEECHAM CORPORATION 2009-05-28 US disclosed
CN-101360498-A Calcilytic compounds SMITHKLINE BEECHAM CORP (US) 2009-02-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137557-A1 Calcilytic Compounds CALCR, SOST, CALCB ALDH1A1 4674/4885MEN1 145/4885HPGD 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.